Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01970397 · ClinicalTrials.gov registry record · NA
JUVEDERM® Ultra XC vs. Belotero Balance® for Perioral Lines
A NA study, sponsored by Allergan.
- Completed
- Registry status
- NA
- Development phase
- 138
- Enrollment target
NCT01970397 is a NA study that has completed, run by Allergan. The registered enrollment target is 138 participants.
The verdict
NCT01970397, a NA study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- NA
- Development phase
- 138 participants
- Enrollment target
Study Summary
A prospective, randomized, controlled, multi-center study of the safety and effectiveness of JUVEDERM® Ultra XC injectable gel versus Belotero Balance® for perioral lines
Interventions
- DEVICE Belotero Balance®
- DEVICE JUVEDERM® Ultra XC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2013-10-21 |
| Est. Completion | 2014-08-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01970397
The ClinicalTrials.gov registry entry for NCT01970397 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Belotero Balance® is the first listed.
NCT01970397 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01970397 about?
NCT01970397 is a clinical study titled "JUVEDERM® Ultra XC vs. Belotero Balance® for Perioral Lines". A prospective, randomized, controlled, multi-center study of the safety and effectiveness of JUVEDERM® Ultra XC injectable gel versus Belotero Balance® for perioral lines
What is the current status of trial NCT01970397?
This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2013-10-21. Estimated completion is 2014-08-04.
What interventions are being tested in trial NCT01970397?
The interventions under investigation include: Belotero Balance® (DEVICE), JUVEDERM® Ultra XC (DEVICE).
Who is sponsoring clinical trial NCT01970397?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.